1. Home
  2. KARO vs LQDA Comparison

KARO vs LQDA Comparison

Compare KARO & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KARO
  • LQDA
  • Stock Information
  • Founded
  • KARO 2001
  • LQDA 2004
  • Country
  • KARO Singapore
  • LQDA United States
  • Employees
  • KARO N/A
  • LQDA N/A
  • Industry
  • KARO Computer Software: Prepackaged Software
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KARO Technology
  • LQDA Health Care
  • Exchange
  • KARO Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • KARO 1.6B
  • LQDA 1.9B
  • IPO Year
  • KARO 2021
  • LQDA 2018
  • Fundamental
  • Price
  • KARO $44.16
  • LQDA $25.77
  • Analyst Decision
  • KARO Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • KARO 4
  • LQDA 10
  • Target Price
  • KARO $58.25
  • LQDA $37.40
  • AVG Volume (30 Days)
  • KARO 72.8K
  • LQDA 2.6M
  • Earning Date
  • KARO 10-14-2025
  • LQDA 11-03-2025
  • Dividend Yield
  • KARO 2.84%
  • LQDA N/A
  • EPS Growth
  • KARO 18.61
  • LQDA N/A
  • EPS
  • KARO 1.82
  • LQDA N/A
  • Revenue
  • KARO $282,977,939.00
  • LQDA $69,216,000.00
  • Revenue This Year
  • KARO $21.18
  • LQDA $424.31
  • Revenue Next Year
  • KARO $15.95
  • LQDA $359.32
  • P/E Ratio
  • KARO $24.12
  • LQDA N/A
  • Revenue Growth
  • KARO 14.75
  • LQDA 343.41
  • 52 Week Low
  • KARO $35.88
  • LQDA $9.71
  • 52 Week High
  • KARO $63.36
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • KARO 36.44
  • LQDA 57.75
  • Support Level
  • KARO $43.10
  • LQDA $22.22
  • Resistance Level
  • KARO $45.30
  • LQDA $29.02
  • Average True Range (ATR)
  • KARO 1.80
  • LQDA 1.85
  • MACD
  • KARO -0.01
  • LQDA 0.46
  • Stochastic Oscillator
  • KARO 20.54
  • LQDA 54.63

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: